XML 21 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Apr. 27, 2019
Apr. 28, 2018
Apr. 29, 2017
Cash flows from operating activities      
Net income $ 70,141 $ 81,595 $ 86,984
Adjustments to reconcile net income to cash provided by operating activities      
Gain on disposal of assets (325) (2,108) (224)
Gain on conversion of investment   (2,204)  
Gain on sale of investments (656) (770) (471)
Change in deferred taxes (1,668) 17,261 569
Change in provision for doubtful accounts 502 276 (291)
Depreciation and amortization 31,147 31,767 29,131
Stock-based compensation expense 10,981 9,474 8,864
Pension termination charge 32,671    
Pension plan contributions (7,000) (2,000) (2,300)
Change in receivables 7,195 (2,801) (7,850)
Change in inventories 3,135 (8,009) 12,517
Change in other assets (7,737) (3,245) (1,211)
Change in accounts payable (2,388) 6,602 4,541
Change in other liabilities 14,747 (10,088) 17,731
Net cash provided by operating activities 150,745 115,750 147,990
Cash flows from investing activities      
Proceeds from disposals of assets 1,941 1,440 761
Proceeds from property insurance 184 2,087  
Capital expenditures (48,433) (36,337) (20,304)
Purchases of investments (20,698) (28,593) (29,763)
Proceeds from sales of investments 20,944 22,674 19,954
Acquisitions, net of cash acquired (76,505) (16,495) (35,878)
Net cash used for investing activities (122,567) (55,224) (65,230)
Cash flows from financing activities      
Payments on debt (223) (262) (288)
Payments for debt issuance costs   (231)  
Stock issued for stock and employee benefit plans, net of shares withheld for taxes 13,901 2,977 1,749
Excess tax benefit on stock option exercises     1,737
Purchases of common stock (22,957) (56,730) (35,957)
Dividends paid (23,508) (22,009) (20,655)
Net cash used for financing activities (32,787) (76,255) (53,414)
Effect of exchange rate changes on cash and equivalents (475) 1,741 178
Change in cash, cash equivalents and restricted cash (5,084) (13,988) 29,524
Cash, cash equivalents and restricted cash at beginning of period 136,871 150,859 121,335
Cash, cash equivalents and restricted cash at end of period 131,787 136,871 150,859
Supplemental disclosure of non-cash investing activities      
Capital expenditures included in payables $ 3,250 $ 5,667 $ 1,795